This study evaluated the antioxidant and possible protective effects of Celosia argentea against tissue injury caused by rifampicin administration. The antioxidant property of the aqueous extract of C. argentea was assessed in-vitro using 2,2-Diphenyl-1-picrylhydrazyl (DPPH), and 2,2-azino-bis (3-ethylbenzthiazoline-6-sufonic acid) (ABTS) assays. The results obtained revealed the free radical scavenging ability of the extract against the radicals in a concentration-dependent manner. Administration of rifampicin to rats for 28 days induced a significant increase in the activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and increase cholesterol levels in the plasma, liver and kidney while HDL cholesterol was decreased. It also elevated the levels of malondialdehyde (MDA) and decreased superoxide dismutase (SOD) activities in the liver and kidney. However, co-administration of C. argentea extract to rifampicin treated rats significantly reversed all these rifampicin induced changes. The levels of AST, ALT, ALP and cholesterol in the plasma, liver and kidney were decreased while HDL cholesterol level was increased. In addition, SOD activity was elevated while MDA was depressed JALSI, 19(4): 1-11, 2018; Article no.JALSI.47000 2 when compared to the rifampicin treated rats. The extract of C. argentea was found to be rich in phenolic content and was proved to have no toxic effects on rats when administered alone to normal rats at a dose level of 400mg/kg/day. This study demonstrated that C. argentea leaf extract ameliorates rifampicin-induced hepatotoxicity and could be exploited in the management of hepatotoxic effect associated with rifampicin treatment.
INTRODUCTION
Tuberculosis (TB) is one of the most common problems in undeveloped and developing countries [1] . It is the ninth principal cause of death worldwide and responsible for the death of 1.7 million people in 2016 alone [2] . Although the rate of new TB infection and mortality are decreasing by about 2% and 3% per year respectively not less than 16% of TB cases resulted in death [3] . Rifampicin which is an important drug used in the treatment of tuberculosis has been reported to induced hepatotoxicity has its main side effect [4] . It is on record that about 5-10% of TB patients that received treatment suffer from hepatotoxicity complication [5] .
The mechanism of hepatotoxicity effect of TB drugs has been linked to their generation of reactive oxygen species (ROS) [6] . Therefore, hepatic toxicity and hepatitis are common features of rifampicin medication and this has been reported to caused steatosis and increased apoptosis of the hepatocytes and hepatic oxidative stress [7] . Though there is no suitable drug to weaken the hepatotoxicity effect of TB drugs presently [8] , herbs are believed to possess potential hepatoprotective agents [9] . Some plant extracts have been shown to contain constituents that improved antioxidant status which is usually depleted during treatment with TB drugs [10, 11] . Many synthetic antioxidants have been shown to produce toxic or mutagenic effects [12] , therefore antioxidants from natural sources will be more appropriate for the prevention of TB drugs toxicity [13] . Celosia argentea L. is an annual herb that belongs to the amaranthaceae family. It has fascinating red flowers and dark green leaves. It is used in traditional medicine for its diuretic, antimitotic, antidiabetic, antihypertensive, anti-inflammatory and antitumor potentials [14, 15] . Phytochemical screenings of the plant detected the presence of phenols, flavonoids, alkaloids, saponins, tannins, terpenes, glycosides, fatty acids, amino acids, carbohydrates and steroids in previous studies [16, 17, 18] . The plant has been demonstrated to possesses hepatoprotective, anti-tumour, antidiarrhoea,
anti-diabetes and anti-oxidant properties in several pharmacological studies [19, 20, 21] .
Therefore, base on reported scientific and traditional evidence for the hepatoprotective potential of C. argentea, this present study was designed to investigate the protective potential of aqueous extract of C. argentea against rifampicin-induced hepatotoxicity.
MATERIALS AND METHODS

Reagents
Trichloroacetic acid (TCA), Folin-Ciocalteau reagent, 6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), 2,2-Diphenyl-1-picrylhydrazyl (DPPH), 2,2-azino-bis (3-ethylbenzthiazoline-6-sufonic acid) ABTS, gallic acid, thiobarbituric acid (TBA), nicotinamide adenine dinucleotide reduced (NADH) were obtained from Sigma-Aldrich Chemical Co. Ltd. (England). Rifampicin was obtained from (Ziel Medicare Ltd, India), while Nitrobluetetrazolium (NBT) was the product of Fluka (Buchs, Switzerland). All other chemicals used were of analytical grade.
Plant Materials
The fresh leaves of C. argentea were collected from the research farm of Faculty of Agricultural science, Ladoke Akintola University of Technology, Ogbomosho. The identification and authentication of the plant were done by Prof A.J. Ogunkunle at Department of Pure and Applied Biology, Ladoke Akintola University of Technology, Ogbomoso, where a specimen was deposited in the herbarium with voucher number UIH 802. The leaves were dried at room temperature and blended to a coarse powder.
Preparation of Aqueous Extract
The powdered leaves of C. argentea (200g) were extracted with distilled water (1.2litres) overnight in a Soxhlet extractor. The aqueous extract was concentrated and evaporated to dryness at 50 o C with a Vacuum air dryer to obtain a flake-type extract and the yield of the preparation was 36.74g (18.37% w/w). The extractive yield was calculated using the relation:
Yield (%) = (Weight of extract (g) / Weight of plant material (g) ) X 100.
Animals
A total of twenty-five (25) male wistar strain albino rats with body weights between 200 and 220g were used in this experiment. They were housed in the Ladoke Akintola University of Technology, (LAUTECH) animal house. They were allowed fourteen (14) days to acclimatize before the commencement of the experiment. The animals were maintained on a standard pellet diet throughout the acclimatization and administration period. 
Experimental Design
Twenty-five (25) male wistar strain albino rats were divided into five groups with each group comprising of five rats. Group 1 rats were given distilled water for 28 days and taken as control, group 2 rats received 400 mg/kg body weight of C. argentea extract only, group 3 rats received 100 mg/kg body weight of rifampicin only, group 4 rats received 100 mg/kg body weight of rifampicin plus 200 mg/kg body weight of C. argentea extract and group 5 rats received 100 mg/kg body weight of rifampicin plus 400 mg/kg body weight of C. argentea extract. Different concentrations of C. argentea extract and rifampicin was administered for a period of 28 days and were given through the oral route with the use of the oral cannula. At the end of the C. argentea treatment, blood was collected from the animals into heparinised tubes by cardiac puncture under light ether anaesthesia and after an overnight fast. Liver and kidney were removed from the animals for biochemical analyses. Blood samples were centrifuged to separate plasma and red blood cells. All samples were stored at -20°C until analysed.
Trolox Equivalent Antioxidant Capacity (TEAC) Assay
The assay was performed essentially as described by Re et al. [22] . ABTS radical cation was produced by reacting 7 mM ABTS stock solution with 2.45 mM potassium persulphate and allowing the mixture to stand in the dark at room temperature for 12-24 h before use. The ABTS 
DPPH (2, 2-Diphenyl-1-picrylhydrazyl) Radical Scavenging Activity
The assay was performed as previously described by Schelesier et al. [23] . The radical solution is prepared by dissolving 2.4 mg DPPH• in 100 ml methanol. For the photometric assay 1.95 ml DPPH• solution and 50 μl antioxidant solution were mixed. At first, the absorbance of the disposable cuvette with 1.95 ml DPPH• was measured as blank, then the antioxidant solution was added and mixed. The reaction was measured at 5 min interval at 515 nm until ΔA=0.003 min-1. The anti-oxidative activity was calculated by determining the decrease in absorbance at different concentrations by using the following equation:
Determination of Total Phenolic Compounds
The content of total phenolic compounds in C. argentea was determined by the Folin-Ciocalteu method as described by Miliauskas et al. [24] . Briefly, l ml aliquots of 0.024, 0.075, 0.0105 and 0.3 mg/ml ethanolic garlic acid solutions were mixed with 5 ml Folin-ciocalteu reagent (diluted ten-fold) and 4 ml (75 g/L) sodium carbonate.
The absorption was read after 30 min at 20˚C at 765 nm and the calibration curve was drawn.
One ml of C. argentea (1 mg/ml) was mixed with the same reagents as described above, and after l h the absorption was measured for the determination of plant phenolics. All determinations were performed in triplicate. The total content of phenolic compounds in plant methanol extracts in gallic acid equivalents (GAE) was calculated by the following formula:
Where: C-total content of phenolic compounds, mg/g plant extract, in GAE; c-the concentration of gallic acid established from the calibration curve, mg/ml; V-the volume of extract, ml; m΄-the weight of pure plant methanolic extract, g.
Preparation of Liver and Kidney Homogenates
Prior to biochemical analyses, the liver and kidney samples were cut into small pieces and homogenized in Phosphate buffer saline (PBS) with a homogenizer to give a 10 % (w/v) liver and kidney homogenate. The homogenates were then centrifuged at 12,000 rpm for 15 min. The supernatant obtained was used for the assay of superoxide dismutase, thiobarbituric acid reactive substances (TBARS) content, and protein estimation.
Determination of Blood Lipid Profiles and ALP, AST, ALT Activities in Plasma
Plasma concentrations of total cholesterol, triglycerides, alkaline phosphatase (ALP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) were determined with commercial kits (CYPRESS® Diagnostics, Langdorp, Belgium). HDL cholesterol and triglycerides were determined in plasma with the same commercial kits for total cholesterol and triglycerides after very low-density lipoproteins (VLDL) and LDL were precipitated with a heparin-MnCl 2 solution [25] .
Liver and Kidney Lipid Profiles
Lipids were extracted from the liver and kidney as described by Folch et al. [26] . After washing with 0.05 M KCl solution, aliquots of the lipid extracts were then used for the determination of lipid profiles. Details of these are given as reported earlier [27] .
Determination of Hepatic and Renal SOD Activities and MDA Levels
Hepatic and renal superoxide dismutase (SOD) activities were assayed in the tissue homogenates by the method of Kakkar et al. [28] at 560 nm. One unit of enzyme activity was defined as that amount of enzyme which caused 50% inhibition of nitrobluetetrazolium reduction/mg protein. The SOD activity was expressed as per mg of protein and the tissue protein was estimated according to the method of Lowry et al. [29] , using bovine serum albumin (BSA) as a standard. The extent of lipid peroxidation was estimated as the concentration of thiobarbituric acid-reactive product malondialdehyde (MDA), using the method of Draper and Hadley [30] .
Statistical Analysis
Results are expressed as mean  S.E.M. The levels of homogeneity among the groups were assessed using One-way Analysis of Variance (ANOVA) followed by Tukey's test. All analyses were done using Graph Pad Prism software Version 5.00 and p values  0.05 were considered statistically significant.
RESULTS
The Total Phenolic Compounds and In-vitro Antioxidant Potential
The C. argentea demonstrated a concentration and time-dependent scavenging activity by quenching DPPH radicals ( Fig. 1 Fig. 1 ). The phenolic content of C. argentea was determined using FolinCiocalteu assay and was found to be 29.57 ± 1.23 mg/g in Gallic acid equivalent (Table 1) .
Effects of the Extract on Blood and Tissue Lipids of Rats
Results of plasma and tissue lipids analyses are presented in Table 2 . Administration of 400 
Effect of Extract on Activities of ALT, ALP and AST
Each value represents the Mean of 5 rats. *(p < 0.05) Groups 2 and 3 (C. argentea and rifampicin treated rat respectively) compared with group 1 (control rats). **(p < 0.05) Groups 4 and 5 (C. argentea treated rats) compared with group 3 (rifampicin treated rats)
respectively and reduction in plasma AST activity by 21.50 % and 34.98 % respectively, when compared with the rats treated with rifampicin only (Fig. 2) .
Effect of Celosia argentea Extract on Hepatic and Renal Malonaldehyde Levels
Hepatic and renal MDA levels of rats treated with rifampicin only were significantly increased by 151.36 % and 246.41 % respectively when compared with the normal rats while administration of 400 mg/kg body weight of C. argentea alone did not produce any significant change in MDA levels. However, coadministration of 200 mg/kg and 400 mg/kg body weight of C. argentea extract to rifampicin treated rats caused a reduction in hepatic MDA level by 25.30 % and 34.94 % respectively, and reduction in renal MDA level by 43.30 % and 51.53 % respectively when compared with the rats treated with rifampicin only (Fig. 3) .
Effect of Celosia argentea Extract on Hepatic and Renal SOD Activity
Hepatic and renal SOD levels of rats treated with rifampicin only were significantly reduced by 68.15 % and 67.00 % respectively when compared with the normal rats while administration of 400 mg/kg of C. argentea alone did not produce any significant change in SOD levels. However, co-administration of 200 mg/kg and 400 mg/kg body weight of C. argentea extract to rifampicin treated rats caused increased in hepatic SOD level was by 56.16 % and 143.84 % respectively and increased in renal SOD level 26.48 % and 114.74 % respectively when compared with the rats treated with rifampicin only (Fig. 4) .
DISCUSSION
Rifampicin a synthetic drug used for TB treatment is known for causing hepatic injury [7] . Rifampicin is a known inducer of many metabolizing enzymes; some metabolites produce through these reactions are toxic and their accumulation would result in the induction of liver injury or immune responses [31] . Rifampicin could also cause the accumulation of reactive oxygen species (ROS) as a result of mitochondrial toxicity [32] . The liver injury caused by chemicals or infectious agents if not treated may progress to liver fibrosis, cirrhosis and liver failure [7] . It has been suggested in previous studies that traditional herbs and micronutrients 
Values are mean ± SEM (n=5). *(p < 0.05) Groups 2 and 3 (C. argentea and rifampicin treated rat respectively) compared with group 1 (control rats). **(p < 0.05) Groups 4 and 5 (C. argentea treated rats) compared with group 3 (rifampicin treated rats)
may help in the prevention of liver injury [33, 34] . In recent time, one plant that has been subjected to several studies for its medicinal values is C. argentea. The current investigation was undertaken to evaluate the possible protective effect of C. argentea against rifampicin-induced hepatotoxicity and oxidative stress in rats.
The ABTS•+ and DPPH radical scavenging assay are among the common methods used to evaluate the total antioxidant activity of vegetables or other plants [33, 34] . In the present study, C. argentea showed DPPH radical scavenging activity which is attributed to its hydrogen donating ability. The extract also showed a strong ABTS radical scavenging ability in a concentration-dependent manner suggesting that C. argentea extract has strong antioxidant potential.
Rats treated with rifampicin in this study developed hepatic damage as revealed by an increase in the activities of ALT, ALP and AST which is in support of previous study [1] . The increased activities of these liver enzymes in the blood are evidence of liver cell damage and loss of functional integrity [35] . There was a reduction in the elevated levels of these enzymes in rats co-administered with C. argentea extract and rifampicin when compared to the rifampicin group only which is an indication of the stabilization of plasma membrane as well as repair of liver damage caused by rifampicin. This observation agrees with the commonly accepted view that serum levels of transaminases return to normal with the healing of hepatic parenchyma and the regeneration of hepatocytes [36] .
Rifampicin administration significantly increases plasma cholesterol level and decrease HDL cholesterol level when compared with the control group a strong indication of disturbances in cholesterol metabolism, a result that agrees with similar studies [8, 37] . Administration of rifampicin also leads to the significant accumulation of cholesterol in the hepatic and renal tissues which is in support of a previous study [38] . In all the compartment, there was a reduction in cholesterol levels of rats co-administered with rifampicin and C. argentea extract when compared with rifampicin group only. Although it is not clear how C. argentea leaf extract reduced the levels of cholesterol, it may be due to its ability to modulate cholesterol metabolism by the liver or lipoprotein lipase activity [39] . The chemical constituents in C. argentea leaf extracts probably downregulate cholesterol biosynthesis or inactivate the enzymatic pathways or both.
Enhanced lipid peroxidation expressed in terms of MDA contents was observed in rifampicintreated rats in our study which indicates the damage to the hepatic and renal cells this agrees with a previous study [3] . Rifampicin is a strong inducer of several metabolizing enzymes thereby resulting in increased accumulation of metabolites, the metabolites can initiate peroxidative damage to lipid membranes and other poly-unsaturated fatty acid-rich structures like endoplasmic reticulum through free radicalmediated reactions [8] . The induced lipid peroxides activated significant upsurge in MDAlike products with a resulting loss in cellular integrity and destruction of liver and kidney tissues. There was a significant reduction in MDA levels of rats simultaneously treated with C. argentea extract and rifampicin when compared to the rifampicin group only, suggesting that the extract inhibit lipid peroxidation and its propagation in the liver and kidney.
The activity of antioxidant enzyme SOD was significantly decreased in hepatic and renal tissues of rifampicin treated rats in this study. The decreased activity of SOD in the liver and kidney tissues of rifampicin treated rats may be due to increased utilisation of the enzyme against reactive oxygen species [40] . However, co-administration of rats with C. argentea extract and rifampicin reversed the reduction in SOD levels when compared to the rifampicin group only, which demonstrates that C. argentea leaf extract protects the liver and kidney from oxidative damage.
Our present study revealed that C. argentea contains a considerable amount of phenolic compounds and exhibited strong free radical scavenging property. A number of researchers have reported that phenolic compounds in plants extract have antioxidant properties in various experimental models [41, 42] . Therefore, the ability of C. argentea to protect the rats against rifampicin induced liver and kidney damaged may be attributed to the presence of phenolic compounds in the extract. The phenolic substances are known to possess the ability to reduce oxidative damage and acts as an antioxidant. They can trap the free radicals directly or scavenge them through a series of coupled reactions with antioxidant enzymes [43] . The hepatoprotective effects of C. argentea demonstrated in this study could be exploited in alleviating xenobiotic-induced hepatotoxicity and nephrotoxicity. This finding justifies the use of C. argentea in traditional medicine, in the prevention of free radical-mediated diseases.
CONCLUSION
The results obtained in this study gave credence to hepatoprotective effects of C. argentea and its use in ethnomedicine. 
